Health Canada authorises Novavax's Nuvaxovid COVID-19 vaccine

Health Canada

17 February 2022 - Today, Health Canada authorised Novavax's Nuvaxovid COVID-19 vaccine for the prevention of COVID-19 in adults 18 years of age and older. 

This is the fifth COVID-19 vaccine authorised in Canada.

Read Health Canada press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Canada , Vaccine , COVID-19